Showing results (1981-1990 of 2,036) with videos related to

Sort By:
Pageof 204
The Journal of Urology|December 14, 2012
Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromesMary P Fitzgerald, Rodney U Anderson, Jeannette Potts, et al.
Nature|March 23, 2010
Intense star formation within resolved compact regions in a galaxy at z = 2.3A M Swinbank, I Smail, S Longmore, et al.
The Journal of Urology|November 21, 2015
Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research NetworkJames W Griffith, Alisa J Stephens-Shields, Xiaoling Hou, et al.
Communications Biology|July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Cancer Research|March 19, 2014
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instabilityKienan I Savage, Kyle B Matchett, Eliana M Barros, et al.
Pain|November 5, 2024
Widespread pain phenotypes impact treatment efficacy results in randomized clinical trials for interstitial cystitis/bladder pain syndrome: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain network studyJohn T Farrar, Kenneth T Locke, J Quentin Clemens, et al.
The Pediatric Infectious Disease Journal|February 14, 2025
Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During PregnancySarah Sturrock, Breeze Cavell, Frances Alexander, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase InhibitorsDerun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.
American Journal of Human Genetics|April 23, 2005
Heterozygous mutations of OTX2 cause severe ocular malformationsNicola K Ragge, Alison G Brown, Charlotte M Poloschek, et al.
Pageof 204